Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activation

Abstract Background Lung cancer is the leading cause of cancer death worldwide. However, the molecular mechanisms underlying lung cancer development have not been fully understood. The functions of histone deacetylases (HDACs), a class of total eighteen proteins (HDAC1–11 and SIRT1–7 in mammals) tha...

Full description

Bibliographic Details
Main Authors: Yubin Lei, Lingling Liu, Shujing Zhang, Shicheng Guo, Xiaoqing Li, Jiucun Wang, Bo Su, Yuchao Fang, Xiaofeng Chen, Hengning Ke, Wufan Tao
Format: Article
Language:English
Published: BMC 2017-11-01
Series:Molecular Cancer
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12943-017-0736-2
id doaj-874dc6d822a741a98810a4b8a098cd30
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Yubin Lei
Lingling Liu
Shujing Zhang
Shicheng Guo
Xiaoqing Li
Jiucun Wang
Bo Su
Yuchao Fang
Xiaofeng Chen
Hengning Ke
Wufan Tao
spellingShingle Yubin Lei
Lingling Liu
Shujing Zhang
Shicheng Guo
Xiaoqing Li
Jiucun Wang
Bo Su
Yuchao Fang
Xiaofeng Chen
Hengning Ke
Wufan Tao
Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activation
Molecular Cancer
Hdac7
Stat3
Acetylation & phosphorylation
Lung cancer
author_facet Yubin Lei
Lingling Liu
Shujing Zhang
Shicheng Guo
Xiaoqing Li
Jiucun Wang
Bo Su
Yuchao Fang
Xiaofeng Chen
Hengning Ke
Wufan Tao
author_sort Yubin Lei
title Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activation
title_short Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activation
title_full Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activation
title_fullStr Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activation
title_full_unstemmed Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activation
title_sort hdac7 promotes lung tumorigenesis by inhibiting stat3 activation
publisher BMC
series Molecular Cancer
issn 1476-4598
publishDate 2017-11-01
description Abstract Background Lung cancer is the leading cause of cancer death worldwide. However, the molecular mechanisms underlying lung cancer development have not been fully understood. The functions of histone deacetylases (HDACs), a class of total eighteen proteins (HDAC1–11 and SIRT1–7 in mammals) that deacetylate histones and non-histone proteins, in cancers are largely unknown. Methods Hdac7 +/−/K-Ras mice and HDAC7-depleted human lung cancer cell lines were used as models for studying the function of Hdac7 gene in lung cancer. Kaplan-Meier survival analysis was performed to explore the relationship between HDAC7 expression and prognosis of human lung cancers. Recombinant lentivirus-mediated in vivo gene expression or knockdown, Western blotting, and pull-down assay were applied to investigate the underlying molecular mechanism by which Hdac7 promotes lung tumorigenesis. Results The number and burden of lung tumor were dramatically reduced in Hdac7 +/−/K-Ras mice compared to control K-Ras mice. Also, in Hdac7 +/−/K-Ras mice, cell proliferation was significantly inhibited and apoptosis in lung tumors was greatly enhanced. Similarly, cell proliferation and anchorage-independent growth of human lung cancer cell lines expressing shHDAC7 were also significantly suppressed and apoptosis was dramatically elevated respectively. Mechanistic study revealed that Hdac7 mutation in mouse lung tumors or HDAC7 depletion in human tumor cell lines resulted in significantly enhanced acetylation and tyrosine-phosphorylation of Stat3 and HDAC7 protein directly interacted with and deacetylateed STAT3. The Hdac7 mutant-mediated inhibitory effects on lung tumorigenesis in mice and cell proliferation/soft agar colony formation of human lung cancer cell lines were respectively reversed by expressing dnStat3. Finally, the high HDAC7 mRNA level was found to be correlated with poor prognosis of human lung cancer patients. Conclusion Our study suggests that Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activation via deacetylating Stat3 and may shed a light on the design of new therapeutic strategies for human lung cancer.
topic Hdac7
Stat3
Acetylation & phosphorylation
Lung cancer
url http://link.springer.com/article/10.1186/s12943-017-0736-2
work_keys_str_mv AT yubinlei hdac7promoteslungtumorigenesisbyinhibitingstat3activation
AT linglingliu hdac7promoteslungtumorigenesisbyinhibitingstat3activation
AT shujingzhang hdac7promoteslungtumorigenesisbyinhibitingstat3activation
AT shichengguo hdac7promoteslungtumorigenesisbyinhibitingstat3activation
AT xiaoqingli hdac7promoteslungtumorigenesisbyinhibitingstat3activation
AT jiucunwang hdac7promoteslungtumorigenesisbyinhibitingstat3activation
AT bosu hdac7promoteslungtumorigenesisbyinhibitingstat3activation
AT yuchaofang hdac7promoteslungtumorigenesisbyinhibitingstat3activation
AT xiaofengchen hdac7promoteslungtumorigenesisbyinhibitingstat3activation
AT hengningke hdac7promoteslungtumorigenesisbyinhibitingstat3activation
AT wufantao hdac7promoteslungtumorigenesisbyinhibitingstat3activation
_version_ 1725187049304096768
spelling doaj-874dc6d822a741a98810a4b8a098cd302020-11-25T01:07:28ZengBMCMolecular Cancer1476-45982017-11-0116111310.1186/s12943-017-0736-2Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activationYubin Lei0Lingling Liu1Shujing Zhang2Shicheng Guo3Xiaoqing Li4Jiucun Wang5Bo Su6Yuchao Fang7Xiaofeng Chen8Hengning Ke9Wufan Tao10Obstetrics & Gynecology Hospital and State Key Laboratory of Genetic Engineering and Institute of Developmental Biology and Molecular Medicine, Collaborative Innovation Center of Genetics and Development, School of Life Sciences, Fudan UniversityObstetrics & Gynecology Hospital and State Key Laboratory of Genetic Engineering and Institute of Developmental Biology and Molecular Medicine, Collaborative Innovation Center of Genetics and Development, School of Life Sciences, Fudan UniversityObstetrics & Gynecology Hospital and State Key Laboratory of Genetic Engineering and Institute of Developmental Biology and Molecular Medicine, Collaborative Innovation Center of Genetics and Development, School of Life Sciences, Fudan UniversityMOE Key Laboratory of Contemporary Anthropology and Collaborative Innovation Center of Genetics and Development, School of Life Sciences, Fudan UniversityObstetrics & Gynecology Hospital and State Key Laboratory of Genetic Engineering and Institute of Developmental Biology and Molecular Medicine, Collaborative Innovation Center of Genetics and Development, School of Life Sciences, Fudan UniversityMOE Key Laboratory of Contemporary Anthropology and Collaborative Innovation Center of Genetics and Development, School of Life Sciences, Fudan UniversityShanghai Pulmonary Hospital, Tongji UniversityHuashan Hospital, Fudan UniversityHuashan Hospital, Fudan UniversityCancer Research Institute, General Hospital, Ningxia Medical UniversityObstetrics & Gynecology Hospital and State Key Laboratory of Genetic Engineering and Institute of Developmental Biology and Molecular Medicine, Collaborative Innovation Center of Genetics and Development, School of Life Sciences, Fudan UniversityAbstract Background Lung cancer is the leading cause of cancer death worldwide. However, the molecular mechanisms underlying lung cancer development have not been fully understood. The functions of histone deacetylases (HDACs), a class of total eighteen proteins (HDAC1–11 and SIRT1–7 in mammals) that deacetylate histones and non-histone proteins, in cancers are largely unknown. Methods Hdac7 +/−/K-Ras mice and HDAC7-depleted human lung cancer cell lines were used as models for studying the function of Hdac7 gene in lung cancer. Kaplan-Meier survival analysis was performed to explore the relationship between HDAC7 expression and prognosis of human lung cancers. Recombinant lentivirus-mediated in vivo gene expression or knockdown, Western blotting, and pull-down assay were applied to investigate the underlying molecular mechanism by which Hdac7 promotes lung tumorigenesis. Results The number and burden of lung tumor were dramatically reduced in Hdac7 +/−/K-Ras mice compared to control K-Ras mice. Also, in Hdac7 +/−/K-Ras mice, cell proliferation was significantly inhibited and apoptosis in lung tumors was greatly enhanced. Similarly, cell proliferation and anchorage-independent growth of human lung cancer cell lines expressing shHDAC7 were also significantly suppressed and apoptosis was dramatically elevated respectively. Mechanistic study revealed that Hdac7 mutation in mouse lung tumors or HDAC7 depletion in human tumor cell lines resulted in significantly enhanced acetylation and tyrosine-phosphorylation of Stat3 and HDAC7 protein directly interacted with and deacetylateed STAT3. The Hdac7 mutant-mediated inhibitory effects on lung tumorigenesis in mice and cell proliferation/soft agar colony formation of human lung cancer cell lines were respectively reversed by expressing dnStat3. Finally, the high HDAC7 mRNA level was found to be correlated with poor prognosis of human lung cancer patients. Conclusion Our study suggests that Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activation via deacetylating Stat3 and may shed a light on the design of new therapeutic strategies for human lung cancer.http://link.springer.com/article/10.1186/s12943-017-0736-2Hdac7Stat3Acetylation & phosphorylationLung cancer